Cargando…
P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort
Autores principales: | Steinack, C., Hage, R., Gautschi, F., Schuurmans, M.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192141/ http://dx.doi.org/10.1016/S1569-1993(21)01163-2 |
Ejemplares similares
-
ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series
por: Gautschi, F., et al.
Publicado: (2022) -
Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
por: Hage, René, et al.
Publicado: (2021) -
Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol
por: Schuurmans, Macé M., et al.
Publicado: (2023) -
Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures
por: Steinack, Carolin, et al.
Publicado: (2022) -
Calcineurin inhibitors revisited: A new paradigm for COVID-19?
por: Hage, René, et al.
Publicado: (2020)